Connect Sign In
ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.
ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.
ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs.
ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).
Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.
Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.
This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey.
Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop.
Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time.
The University of Utah Licensing and Technology Office awards recognize impactful research and innovation. Though retired, Wittwer is active in advancing molecular diagnostics and mentoring others.
